'Hyngry bone syndrome': after tertiary hypeparathyroidism treatment

Bone marrow necrosis after treatment with sulphasalazine.

[Bone aging and frailty syndrome after 10 years of ARV treatment in Senegal].

This study compares two indicators of aging (bone loss and frailty syndrome) between patients of the cohort and age- and sex-matched subjects from the general population in Dakar. It shows that patients had a lower mineral bone density. By contrast, the prevalence of frailty (an indicator of general health status and physical condition) among patients was similar to the general population.

cost benefits of rehabilitation after acute coronary syndrome in iran; using an epidemiological model

چکیده ندارد.

Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome

Background: Release of vascular endothelial growth factor (VEGF) by ovaries in response to HCG administration is one of the main mechanisms of ovarian hyper stimulation syndrome. Since Dopamine/dopamine receptor2 (Dp-r2) pathway activity -mediated by VEGF/ Vascular endothelial growth factor receptor 2 (VEGFR-2) signaling-, is associated with angiogenic events, dopamine agonists were used for th...

Marked increase in bone formation markers after cinacalcet treatment by mechanisms distinct from hungry bone syndrome in a haemodialysis patient

A 59-year-old female who was on dialysis due to diabetic nephropathy was referred to our hospital for severe hyperparathyroidism refractory to intravenous vitamin D receptor activator treatment. With subsequent cinacalcet hydrochloride treatment, parathyroid hormone (PTH) levels were only slightly suppressed. However, progressive increases were observed in serum alkaline phosphatase (ALP) and b...